Abiopharma

🔍 Grier Kelly J (Director)

Company: AT&T INC. (T)

Report Date: 2026-04-30

Detailed Transactions and Holdings:

• Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-30 | Code: H | shares_owned_after: 723.00
• Acquired 59 shares of Deferred Stock Units (Derivative)
  Date: 2026-04-30 | Code: A | equity_swap_involved: 0 | shares_owned_after: 5,642.99 | transaction_form_type: 4 | Footnotes: F1, F1, F1

Footnotes:

• F1: Deferred stock units acquired pursuant to the AT&T Inc. Non-Employee Director Stock and Deferral Plan. After the reporting person ceases to be a director, each unit is paid out in cash equal to the value of one share of AT&T common stock at times elected by the director.